Distribution of global respiratory-immunology market by condition 2024

This statistic displays the global respiratory therapy market by condition based on the MAT (moving annual total) until the third quarter of 2024 (October 2023 to September 2024). In that year, the global asthma therapy market generated nearly 30 billion U.S. dollars. Asthma is a major cause of morbidity and mortality globally, and it is thought to have become more prevalent in the last decades. Fixed combination doses of preventative and symptomatic treatments are used to combat moderate to severe asthma.